OBJ Ltd has made several appointments to its subsidiary, OBJ Transdermal Vaccines, a vehicle that will develop the company’s technology for delivery of vaccines through the skin. Dr Ian Frazer, developer of the Gardasil cervical cancer vaccine, has been appointed to the scientific advisory board to advise the company on the project. Dr Ken Donald, former head of the School of Medicine at the University of Queensland, has been appointed chairman of OBJTV and Dr Gil Shearer as director and CEO.